Hong Kong SAR

Chinese biotechnology company JW (Cayman) Therapeutics is planning to float on Hong Kong’s stock exchange. It has filed a draft prospectus with the bourse.

Yuexiu Transport Infrastructure, a Hong Kong-listed red Panda issuer, returned to the renminbi market this week for a small Rmb500m ($72m) bond. The issuer wrapped up the deal after extending the bookbuilding period by half a day.

Hong Kong-listed Summit Ascent Holdings, an investment holding company focused on operating resorts, is planning a rights issue worth HK$1.6bn ($206m).

Cigarette packaging producer Amvig Holdings has closed its HK$1.35bn ($174m) loan with seven lenders.

Hong Kong rail operator MTR Corp priced a larger and tighter green bond than expected this week, with investors showing their faith in a company that has been forced to battle protests and the pandemic in the past year. Morgan Davis reports.

Deutsche promotes Elalingam to IB coverage job — JPM hires Aus head of financial sponsors

After months of lockdown in countries across the world, a few of my banker friends are now slowly heading back to their offices. It is not easy.

Hong Kong-based Li & Fung used a coupon step-up in case of a rating downgrade to attract investors to its $300m bond on Tuesday, as it gears up for a big hit to its business this year as a result of Covid-19.

China Education Group Holding has raised HK$2bn ($260m) after boosting the size of a top-up share placement.

Hong Kong-listed Shanghai Henlius Biotech has won approval from the Mainland securities regulator to sell a chunk of new shares.

BMW Finance, a subsidiary of German carmaker BMW, sealed a Rmb500m ($72m) three year dim sum bond on Thursday. It was the first publicly sold offshore renminbi trade by a corporation since November last year.

China’s Excellence Commercial Property and Facilities Management Group is preparing to launch its Hong Kong IPO this month, according to a source close to the deal.